Navigation Links
Schering-Plough Reports Financial Results for 2009 First Quarter
Date:4/21/2009

reatment of chronic hepatitis C patients 3 years of age and older with compensated liver disease who have failed prior therapy. (Announced March 11)
  • Reported on a Phase II study published in The Lancet of the company's novel oral thrombin receptor antagonist (TRA), which showed no increase in TIMI major and minor bleeding and was well tolerated when given with standard platelet therapy. (Announced March 12)
  • Initiated the first-in-human clinical development program for a new intranasal Live Attenuated Influenza Vaccine for annual seasonal use by Nobilon, Schering-Plough's human vaccine business unit. (Announced March 13)
  • Named a 2009 ENERGY STAR Partner of the Year by the U.S. Environmental Protection Agency for outstanding energy management and reductions in greenhouse gas emissions. (Announced March 30)
  • Reported on a study showing that early use of an investigational dose of INTEGRILIN in patients with Acute Coronary Syndrome was not superior to delayed provisional use. (Announced March 30)
  • Reported on the Dieter Luetticken Award 2008 for alternatives in animal testing, sponsored by Intervet/Schering-Plough Animal Health. (Announced April 7)
  • Gained approval in Canada for SIMPONI, the first once-monthly, subcutaneous therapy for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, marking the first approval in the world for this innovative new product. (Announced April 13)

  • First Quarter 2009 Conference Call and Webcast

    Schering-Plough will conduct a conference call today at 7:30 a.m. (EDT) to review the 2009 first quarter results. To listen live to the call, dial 1-877-565-9664 or 1-706-634-5003 and enter conference ID # 87621385. A replay of the call will be available beginning later on April 21 through 5 p.m. on April 28. To listen to the replay, dial 1-800-642-1687 o
    '/>"/>

    SOURCE Schering-Plough Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine news :

    1. EPA Names Schering-Plough 2009 EPA ENERGY STAR(R) Partner of the Year
    2. Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M.
    3. Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference
    4. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
    5. Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
    6. Schering-Plough Selects Benefit Advocates for Health Advocacy
    7. Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings
    8. Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
    9. Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R)
    10. Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
    11. Schering-Plough to Webcast R&D Update Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2014)... To kick off the fall season ... One Spas retailers across the country are offering 0% ... The Hot Tub Tailgate Event is from August 29th-September ... more information and to apply early! , As the ... wide variety of outdoor hot tubs with exclusive features ...
    (Date:8/28/2014)... Somerset, N.J. (PRWEB) August 28, 2014 ... of advanced delivery technologies and development solutions for ... that Kristen DeVito, Global Director Clinical Supply Services, ... will present “Critical Path Sourcing Strategies for Active ... Trials Supply Conference, which takes place on the ...
    (Date:8/28/2014)... nasal septum cells. Researchers at the University and the ... the nasal septum are able to adapt to the ... articular cartilage defects. The nasal cartilage cells, ability to ... with the expression of so-called HOX genes. The scientific ... research results together with the report of the first ...
    (Date:8/28/2014)... who identify themselves as ,old, feel worse about their ... lower value than younger age groups. , New research ... old and ill, across different countries: social status, age ... the European Social Survey. Respondents, who were all aged ... The researchers found that those living in societies where ...
    (Date:8/28/2014)... (PRWEB) August 28, 2014 BCC Research ... SURGICAL NAVIGATION SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS , the ... $419.7 million in 2013. Driven by the need for ... medical tourism in emerging geographies, the market is expected ... growth rate (CAGR) of 8.5% from 2013 through 2018. ...
    Breaking Medicine News(10 mins):Health News:Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference 2Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 2Health News:Global Market for Surgical Navigation Systems Expected to Reach $631.9 Million in 2018; ENT Systems Segment Leading With 10.4% CAGR 3
    ... In order to expand the range and reach of its affiliate ... Network this February. This is in addition to the company,s already ... ... Diego, CA (PRWEB) March 26, 2009 -- In order to expand ...
    ... a protein that helps prevent tumours spreading and growing ... many different types of cancer. In a study published ... , Canadian researchers modified the tumour inhibiting protein, von ... growth in mice. , When solid tumours grow they ...
    ... March 25 While dollars for infrastructure and construction ... becoming known that nearly $22 billion in stimulus funds ... across the nation. As the federal government works to ... Reinvestment Act of 2009 will be allocated, ...
    ... The U.S. Agency for International Development,s (USAID) ... providing more than $3.7 million in assistance to ... of families in Senegal.Of this $3.7 million, USAID ... efforts and agriculture production in the regions of ...
    ... The California Transplant Donor Network today issued the following statement on ... the line of duty: "Our hearts go out to the family ... community. Officer Hege was registered on the Donate Life California ... chose in death as he did in life to help those ...
    ... Demonstration on Anakam,s Authentication SolutionsSAN DIEGO, March 25 Anakam,s ... John Macaulay will be giving a presentation on two-factor authentication ... Place. The presentation will take place at 4:15 p.m. ... discussing issues healthcare faces in the age of electronic health ...
    Cached Medicine News:Health News:TestCountry.com Expands Its Affiliate Reach with Google Affiliate Network 2Health News:TestCountry.com Expands Its Affiliate Reach with Google Affiliate Network 3Health News:Bioengineered proteins: Trial confirms new way to tackle cancer 2Health News:GlobalMedia Provides Free Grant Writing and Application Assistance to Healthcare Providers and Professionals Seeking Their Share of Billions in Economic Stimulus Dollars 2Health News:California Transplant Donor Network Issues Statement on Officer John Hege's Donation 2Health News:Dr. William 'Bill' Braithwaite and Dr. John Macaulay Present Anakam's Two-Factor Authentication Platform at HIMSS 2009 Annual Conference and Exhibition 2
    (Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
    (Date:8/28/2014)... Telik, Inc. (OTCQB: TELK), a clinical ... MabVax Therapeutics, Inc. on July 8, 2014, announced ... the development of its lead antibody program designated ... Company,s internally developed antibody discovery platform.  These preclinical ... based therapeutic and diagnostic products based on this ...
    (Date:8/28/2014)... 2014  Rx Safes, Inc., the manufacturer of fingerprint ... waging a new war on drugs to reduce prescription ... More than 2,500 children a day experiment with ... are easily accessed from unsecured medicine cabinets, closets and drawers. ... streets, Rx Safes will address the new age drug ...
    Breaking Medicine Technology:Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4Rx Safes, Inc. Announces New War On Drugs 2
    ... Study of Zalutumumab in Combination, With Radiotherapy ... COPENHAGEN, June 24 Genmab A/S (OMX: GEN),announced ... zalutumumab,(HuMax-EGFr(TM)) in combination with radiotherapy for the treatment of,advanced ... maximum of 36,patients who are ineligible for platinum based ...
    ... New Recommendations Address Presurgery and Pediatric Dilemmas, ... evidence-based guidelines,address the prevention and management of ... related to the routine use of,preventive therapies. ... issue of CHEST,the peer-reviewed journal of the ...
    Cached Medicine Technology:Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 2Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 3Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 2Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 3Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 4
    BETADINE Solution Swab Aid antiseptic pads are for quick and easy skin degerming. Individually wrapped pads, saturated with 10% povidone-iodine solution, offer the advantages of BETADINE Solution in ...
    IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
    BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
    BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
    Medicine Products: